Skip to main content
OpenTrials
Completed

NCT Number: NCT06616662

Transsphincteric Fistula Management Using LIFT and MAF

a study that detect the most suitable surgical techniques for treating transsphincteric fistula

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Perianal Fistula

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine Zagazig University

Zagazig, Sharqia Province, 44511, Egypt

About this study

we compared between LIFT and MAF in elderly with PAF

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • elderly persons with PAF

Exclusion criteria

  • recurrent fistula
  • associated autoimmune diseases

Treatment and study plan

MAF

Procedure

use mucosal advancement flap to treat PAF

LIFT

Procedure

use LIFT surgery for treating PAF

Primary outcomes

  1. healing rate

    Time frame: three years

    incidence of healing in both approaches

Secondary outcomes

  1. incontinence

    Time frame: three years

    incidence of incontinence after both approaches

Sponsors and collaborators

Lead sponsor

Zagazig University

Other Gov

Registry information

Official study title

Comparative Outcomes of Ligation of the Intersphincteric Fistula Tract and Mucosal Advancement Flap Techniques in Elderly Patients with Transsphincteric Perianal Fistulas: Recurrence, Incontinence and Risk Factors

Important dates

Study start
2018
Primary completion
2021
Study completion
2024
First posted
Sep 27, 2024
Registry last updated
Sep 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.